Research graph
References from Impact of adjunctive venoactive drug therapy on symptom relief and quality of life following radiofrequency ablation for symptomatic great saphenous vein incompetence. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.jvsv.2024.101842
10.1016/j.jvsv.2024.101842 · External reference
10.1177/02683555211060622
10.1177/02683555211060622 · External reference
10.1016/j.ejvs.2021.12.024
10.1016/j.ejvs.2021.12.024 · External reference
10.1016/j.jvsv.2023.08.011
10.1016/j.jvsv.2023.08.011 · External reference
10.1177/02683555221114537
10.1177/02683555221114537 · External reference
10.1177/17085381211058587
10.1177/17085381211058587 · External reference
10.1016/j.jvsv.2025.102258
10.1016/j.jvsv.2025.102258 · External reference
10.2106/jbjs.23.00854
10.2106/jbjs.23.00854 · External reference
10.1308/rcsann.2020.0116
10.1308/rcsann.2020.0116 · External reference
10.1016/j.jvsv.2023.03.015
10.1016/j.jvsv.2023.03.015 · External reference
10.1002/bjs.10961
10.1002/bjs.10961 · External reference
10.1007/s12325-019-0881-7
10.1007/s12325-019-0881-7 · External reference
10.1177/02683555231169088
10.1177/02683555231169088 · External reference
10.3390/pharmaceutics17010059
10.3390/pharmaceutics17010059 · External reference
10.3390/molecules24183316
10.3390/molecules24183316 · External reference
10.23736/s0392-9590.18.03975-5
10.23736/s0392-9590.18.03975-5 · External reference
10.1080/07315724.2021.1909510
10.1080/07315724.2021.1909510 · External reference
10.1177/02683555211002331
10.1177/02683555211002331 · External reference
10.1007/s12325-019-01216-w
10.1007/s12325-019-01216-w · External reference
10.1007/s12325-018-0731-z
10.1007/s12325-018-0731-z · External reference
10.3390/nu13030999
10.3390/nu13030999 · External reference
Monocyte chemoattractant protein 1 plasma concentration in blood from varicose veins decreases under venoactive drug treatment
2022 · External reference
10.2106/jbjs.23.01264
10.2106/jbjs.23.01264 · External reference
10.33529/angi02020201
10.33529/angi02020201 · External reference
10.1002/bjs.10961
10.1002/bjs.10961 · ExternalCitation · doi-reference
10.1007/s12325-018-0731-z
10.1007/s12325-018-0731-z · ExternalCitation · doi-reference
10.1007/s12325-019-01216-w
10.1007/s12325-019-01216-w · ExternalCitation · doi-reference
10.1007/s12325-019-0881-7
10.1007/s12325-019-0881-7 · ExternalCitation · doi-reference
10.1016/j.ejvs.2021.12.024
10.1016/j.ejvs.2021.12.024 · ExternalCitation · doi-reference
10.1016/j.jvsv.2023.03.015
10.1016/j.jvsv.2023.03.015 · ExternalCitation · doi-reference
10.1016/j.jvsv.2023.08.011
10.1016/j.jvsv.2023.08.011 · ExternalCitation · doi-reference
10.1016/j.jvsv.2024.101842
10.1016/j.jvsv.2024.101842 · ExternalCitation · doi-reference
10.1016/j.jvsv.2025.102258
10.1016/j.jvsv.2025.102258 · ExternalCitation · doi-reference
10.1080/07315724.2021.1909510
10.1080/07315724.2021.1909510 · ExternalCitation · doi-reference
10.1177/02683555211002331
10.1177/02683555211002331 · ExternalCitation · doi-reference
10.1177/02683555211060622
10.1177/02683555211060622 · ExternalCitation · doi-reference
10.1177/02683555221114537
10.1177/02683555221114537 · ExternalCitation · doi-reference
10.1177/02683555231169088
10.1177/02683555231169088 · ExternalCitation · doi-reference
10.1177/17085381211058587
10.1177/17085381211058587 · ExternalCitation · doi-reference
10.1308/rcsann.2020.0116
10.1308/rcsann.2020.0116 · ExternalCitation · doi-reference
10.2106/jbjs.23.00854
10.2106/jbjs.23.00854 · ExternalCitation · doi-reference
10.2106/jbjs.23.01264
10.2106/jbjs.23.01264 · ExternalCitation · doi-reference
10.23736/s0392-9590.18.03975-5
10.23736/s0392-9590.18.03975-5 · ExternalCitation · doi-reference
10.33529/angi02020201
10.33529/angi02020201 · ExternalCitation · doi-reference
10.3390/molecules24183316
10.3390/molecules24183316 · ExternalCitation · doi-reference
10.3390/nu13030999
10.3390/nu13030999 · ExternalCitation · doi-reference
10.3390/pharmaceutics17010059
10.3390/pharmaceutics17010059 · ExternalCitation · doi-reference
